A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India
Latest Information Update: 01 Feb 2021
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Expanded access; Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 14 Mar 2017 New trial record
- 07 Mar 2017 Status changed to completed.